Planning for the 2025 NAB Show is ramping up, and Radio World is asking exhibitors about their plans and expectations.

The one-time therapy appears to correct the mutation that causes the disease, known as Alpha-1 antitrypsin deficiency (AATD), ...

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

BEAM-302 "has set the bar for efficacy in this space," William Blair analysts wrote in an investor note on Monday.

We recently published an article titled These 10 Dividend Stocks are Underperforming in 2025. In this article, we are going ...

The author is looking forward to seeing how Beam Therapeutics would do in their clinical trials of single-base DNA editing.

Detailed price information for American Assets Trust (AAT-N) from The Globe and Mail including charting and trades.

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in ...

Covenant Logistics is proud to recognize Landair, a Covenant Logistics Group Company, and AAT Carriers, a Covenant Logistics Group Company, for their selection as 2025 TCA Elite Fleet Certified ...

Thinking of pursuing an accounting qualification? We explore the different roles you could be qualified for after completing ...